Stocks
Globe Life Financial Statements (GL) |
||||||||||
| Globe Lifesmart-lab.ru | % | 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 28.02.2024 | 31.03.2024 | 08.05.2024 | 07.08.2024 | 06.11.2024 | 06.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 1 416 | 1 416 | 1 416 | 1 440 | 1 455 | 5 728 | |||
| Operating Income, bln rub | 1 226 | 343.5 | 343.5 | 1 239 | 1 141 | 3 068 | ||||
| EBITDA, bln rub | ? | 0.000 | -28.6 | 0.000 | 0.000 | 408.3 | 379.7 | |||
| Net profit, bln rub | ? | 274.8 | 254.2 | 254.2 | 258.4 | 303.0 | 1 070 | |||
| OCF, bln rub | ? | 391.4 | 0.000 | 350.8 | 374.1 | 340.6 | 1 066 | |||
| CAPEX, bln rub | ? | 13.1 | 0.000 | 9.11 | 17.6 | 29.3 | 56.0 | |||
| FCF, bln rub | ? | 378.3 | 0.000 | 341.7 | 356.5 | 311.3 | 1 009 | |||
| Dividend payout, bln rub | 21.2 | 0.000 | 21.1 | 22.6 | 21.6 | 65.3 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 7.70% | 0.00% | 8.31% | 8.73% | 7.13% | 6.10% | ||||
| OPEX, bln rub | 189.3 | 1 073 | 186.7 | 201.0 | 209.2 | 1 670 | ||||
| Cost of production, bln rub | 91.8 | 0.000 | 93.2 | 99.1 | 104.9 | 297.2 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 25.7 | 0.000 | 28.6 | 31.4 | 31.4 | 91.4 | ||||
| Assets, bln rub | 28 051 | 0.000 | 28 571 | 28 299 | 29 557 | 29 557 | ||||
| Net Assets, bln rub | ? | 4 487 | 4 487 | 5 039 | 5 228 | 4 639 | 4 639 | |||
| Debt, bln rub | 2 116 | 0.000 | 2 364 | 2 285 | 2 761 | 2 761 | ||||
| Cash, bln rub | 18 055 | 0.000 | 18 286 | 17 801 | 235.1 | 235.1 | ||||
| Net debt, bln rub | -15 939 | 0.00 | -15 923 | -15 516 | 2 526 | 2 526 | ||||
| Ordinary share price, rub | 121.7 | 116.4 | 116.4 | 82.3 | 105.9 | 115.9 | ||||
| Number of ordinary shares, mln | 94.1 | 95.2 | 93.9 | 93.9 | 87.9 | 87.9 | ||||
| Market cap, bln rub | 11 455 | 11 080 | 10 923 | 7 723 | 9 307 | 10 180 | ||||
| EV, bln rub | ? | -4 484 | 11 080 | -5 000 | -7 793 | 11 833 | 12 706 | |||
| Book value, bln rub | -2 004 | 4 487 | -1 574 | -1 514 | 4 148 | 4 148 | ||||
| EPS, rub | ? | 2.92 | 2.67 | 2.71 | 2.75 | 3.45 | 12.2 | |||
| FCF/share, rub | 4.02 | 0.00 | 3.64 | 3.80 | 3.54 | 11.5 | ||||
| BV/share, rub | -21.3 | 47.1 | -16.8 | -16.1 | 47.2 | 47.2 | ||||
| EBITDA margin, % | ? | 0.00% | -2.02% | 0.00% | 0.00% | 28.1% | 6.63% | |||
| Net margin, % | ? | 19.4% | 18.0% | 18.0% | 17.9% | 20.8% | 18.7% | |||
| FCF yield, % | ? | 12.5% | 8.70% | 12.0% | 17.5% | 14.9% | 9.92% | |||
| ROE, % | ? | 21.6% | 22.3% | 19.9% | 20.0% | 23.5% | 23.1% | |||
| ROA, % | ? | 3.46% | 3.50% | 3.69% | 3.69% | 3.62% | ||||
| P/E | ? | 11.8 | 11.1 | 10.9 | 7.39 | 8.54 | 9.52 | |||
| P/FCF | 7.99 | 11.5 | 8.37 | 5.71 | 6.71 | 10.1 | ||||
| P/S | ? | 2.10 | 2.00 | 1.97 | 1.37 | 1.62 | 1.78 | |||
| P/BV | ? | -5.71 | 2.47 | -6.94 | -5.10 | 2.24 | 2.45 | |||
| EV/EBITDA | ? | -7.96 | 21.0 | -18.9 | 29.0 | 33.5 | ||||
| Debt/EBITDA | -28.3 | 0.00 | -60.2 | 6.19 | 6.65 | |||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| CAPEX/Revenue, % | 0.93% | 0.00% | 0.64% | 1.22% | 2.01% | 0.98% | ||||
| Globe Life shareholders | ||||||||||
